ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
ZIM Laboratories completed incorporation of its wholly-owned Chilean subsidiary, ZIM Laboratories SpA. The LATAM expansion entity is now operational, marking completion of the February 2026 board-approved plan.
ZIM Laboratories Limited incorporated a wholly owned subsidiary, 'ZIM Laboratories SpA', in Chile. This expansion aims to develop its pharmaceutical business in the LATAM region.
Zim Laboratories confirmed that its subsidiary, ZIM FZE, completed the previously announced AED 9,16,000 investment in its step-down subsidiary, ZIM Scientific Office LLC.
ZIM Laboratories Limited has invested Rs. 0.89 Crore (AUD 1,35,000) into its subsidiary ZIMTAS Pty Ltd. This investment is part of a total approved amount of up to Rs. 2 Crore for equity shares in the subsidiary.
Zim Laboratories Limited invested ₹0.89 Crore (AUD 1,35,000) into the equity shares of its subsidiary, ZIMTAS Pty Ltd. Following this investment, the company now holds 99.96% of the subsidiary's total share capital. This move follows an approved investment limit of up to ₹2.00 Crore.